These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21330923)

  • 1. Update on targeted therapies for clear cell renal cell carcinoma.
    Singer EA; Gupta GN; Srinivasan R
    Curr Opin Oncol; 2011 May; 23(3):283-9. PubMed ID: 21330923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapeutic strategies for the management of renal cell carcinoma.
    Singer EA; Gupta GN; Srinivasan R
    Curr Opin Oncol; 2012 May; 24(3):284-90. PubMed ID: 22343386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent updates in renal cell carcinoma.
    Rathmell WK; Godley PA
    Curr Opin Oncol; 2010 May; 22(3):250-6. PubMed ID: 20154618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.
    Costa LJ; Drabkin HA
    Oncologist; 2007 Dec; 12(12):1404-15. PubMed ID: 18165617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?
    Martinez Chanza N; Tripathi A; Harshman LC
    Curr Treat Options Oncol; 2019 May; 20(5):44. PubMed ID: 31054006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and obstacles to combination targeted therapy in renal cell cancer.
    Sosman JA; Puzanov I; Atkins MB
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):764s-769s. PubMed ID: 17255307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: molecular biology and targeted therapy.
    Su D; Stamatakis L; Singer EA; Srinivasan R
    Curr Opin Oncol; 2014 May; 26(3):321-7. PubMed ID: 24675233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for renal cancer.
    Haviv YS; Curiel DT
    Contrib Nephrol; 2008; 159():135-150. PubMed ID: 18391590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies.
    Golshayan AR; Brick AJ; Choueiri TK
    Future Oncol; 2008 Feb; 4(1):85-92. PubMed ID: 18241003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating biomarkers in advanced renal cell carcinoma: clinical applications.
    Hernandez-Yanez M; Heymach JV; Zurita AJ
    Curr Oncol Rep; 2012 Jun; 14(3):221-9. PubMed ID: 22434312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced treatments in non-clear renal cell carcinoma.
    Tazi el M; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
    Urol J; 2011; 8(1):1-11. PubMed ID: 21404194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing landscape of systemic therapy in metastatic renal cell carcinoma: an update.
    Gurram S; Al Harthy M; Ball MW
    Discov Med; 2020; 29(158):191-199. PubMed ID: 33007194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targeted therapy for advanced renal carcinoma: trials in progress.
    Calabrò F; Sternberg CN
    Curr Opin Urol; 2010 Sep; 20(5):382-7. PubMed ID: 20625300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New treatments for renal cell carcinoma: targeted therapies.
    Saylor PJ; Michaelson MD
    J Natl Compr Canc Netw; 2009 Jun; 7(6):645-56. PubMed ID: 19555586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.